Mitochondrial oxidative stress impairs contractile function but paradoxically increases muscle mass via fibre branching.

Fibre branching Hyperplasia Mitochondria MnSOD Reactive oxygen species Skeletal muscle

Journal

Journal of cachexia, sarcopenia and muscle
ISSN: 2190-6009
Titre abrégé: J Cachexia Sarcopenia Muscle
Pays: Germany
ID NLM: 101552883

Informations de publication

Date de publication:
04 2019
Historique:
received: 19 07 2018
accepted: 12 11 2018
pubmed: 2 2 2019
medline: 2 2 2019
entrez: 2 2 2019
Statut: ppublish

Résumé

Excess reactive oxygen species (ROS) and muscle weakness occur in parallel in multiple pathological conditions. However, the causative role of skeletal muscle mitochondrial ROS (mtROS) on neuromuscular junction (NMJ) morphology and function and muscle weakness has not been directly investigated. We generated mice lacking skeletal muscle-specific manganese-superoxide dismutase (mSod2KO) to increase mtROS using a cre-Lox approach driven by human skeletal actin. We determined primary functional parameters of skeletal muscle mitochondrial function (respiration, ROS, and calcium retention capacity) using permeabilized muscle fibres and isolated muscle mitochondria. We assessed contractile properties of isolated skeletal muscle using in situ and in vitro preparations and whole lumbrical muscles to elucidate the mechanisms of contractile dysfunction. The mSod2KO mice, contrary to our prediction, exhibit a 10-15% increase in muscle mass associated with an ~50% increase in central nuclei and ~35% increase in branched fibres (P < 0.05). Despite the increase in muscle mass of gastrocnemius and quadriceps, in situ sciatic nerve-stimulated isometric maximum-specific force (N/cm Increased skeletal muscle mtROS is sufficient to elicit NMJ disruption and contractile abnormalities, but not muscle atrophy, suggesting new roles for mitochondrial oxidative stress in maintenance of muscle mass through increased fibre branching.

Sections du résumé

BACKGROUND
Excess reactive oxygen species (ROS) and muscle weakness occur in parallel in multiple pathological conditions. However, the causative role of skeletal muscle mitochondrial ROS (mtROS) on neuromuscular junction (NMJ) morphology and function and muscle weakness has not been directly investigated.
METHODS
We generated mice lacking skeletal muscle-specific manganese-superoxide dismutase (mSod2KO) to increase mtROS using a cre-Lox approach driven by human skeletal actin. We determined primary functional parameters of skeletal muscle mitochondrial function (respiration, ROS, and calcium retention capacity) using permeabilized muscle fibres and isolated muscle mitochondria. We assessed contractile properties of isolated skeletal muscle using in situ and in vitro preparations and whole lumbrical muscles to elucidate the mechanisms of contractile dysfunction.
RESULTS
The mSod2KO mice, contrary to our prediction, exhibit a 10-15% increase in muscle mass associated with an ~50% increase in central nuclei and ~35% increase in branched fibres (P < 0.05). Despite the increase in muscle mass of gastrocnemius and quadriceps, in situ sciatic nerve-stimulated isometric maximum-specific force (N/cm
CONCLUSIONS
Increased skeletal muscle mtROS is sufficient to elicit NMJ disruption and contractile abnormalities, but not muscle atrophy, suggesting new roles for mitochondrial oxidative stress in maintenance of muscle mass through increased fibre branching.

Identifiants

pubmed: 30706998
doi: 10.1002/jcsm.12375
pmc: PMC6463475
doi:

Types de publication

Journal Article Research Support, U.S. Gov't, Non-P.H.S. Research Support, N.I.H., Extramural

Langues

eng

Sous-ensembles de citation

IM

Pagination

411-428

Subventions

Organisme : NIA NIH HHS
ID : R01 AG050676
Pays : United States
Organisme : NIGMS NIH HHS
ID : K12 GM111725
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG047879
Pays : United States
Organisme : NIA NIH HHS
ID : P30 AG050911
Pays : United States
Organisme : NIA NIH HHS
ID : R01 AG055395
Pays : United States
Organisme : NIGMS NIH HHS
ID : P20 GM103447
Pays : United States
Organisme : NIA NIH HHS
ID : T32 AG052363
Pays : United States
Organisme : NIGMS NIH HHS
ID : P30 GM114731
Pays : United States
Organisme : NIA NIH HHS
ID : P01 AG051442
Pays : United States

Commentaires et corrections

Type : ErratumIn

Informations de copyright

© 2019 The Authors. Journal of Cachexia, Sarcopenia and Muscle published by John Wiley & Sons Ltd on behalf of the Society on Sarcopenia, Cachexia and Wasting Disorders.

Références

J Cachexia Sarcopenia Muscle. 2017 Jun;8(3):349-369
pubmed: 28432755
Biochem J. 2008 Jan 15;409(2):491-9
pubmed: 17916065
Methods Mol Biol. 2015;1264:245-61
pubmed: 25631019
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):881-906
pubmed: 28744984
Proc Natl Acad Sci U S A. 1996 Sep 3;93(18):9782-7
pubmed: 8790408
Am J Physiol Regul Integr Comp Physiol. 2011 Nov;301(5):R1400-7
pubmed: 21900648
Nat Rev Mol Cell Biol. 2015 Jun;16(6):345-59
pubmed: 25970558
Muscle Nerve. 1988 Aug;11(8):795-803
pubmed: 3173406
Mech Ageing Dev. 2006 Nov;127(11):849-61
pubmed: 17002888
Free Radic Res. 2011 Jan;45(1):29-36
pubmed: 21110783
Age (Dordr). 2016 Aug;38(4):323-333
pubmed: 27444179
Arthritis Res Ther. 2015 Mar 10;17:54
pubmed: 25889867
J Neurol Neurosurg Psychiatry. 1964 Oct;27:361-80
pubmed: 14213465
J Biol Chem. 1998 Oct 23;273(43):28510-5
pubmed: 9774481
Proc Natl Acad Sci U S A. 2017 Mar 7;114(10):2705-2710
pubmed: 28223503
Physiol Rev. 2008 Oct;88(4):1243-76
pubmed: 18923182
Mech Ageing Dev. 2006 Mar;127(3):298-306
pubmed: 16405961
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):926-938
pubmed: 28845591
Mech Ageing Dev. 1991 Sep;60(1):43-53
pubmed: 1745064
FASEB J. 2010 May;24(5):1376-90
pubmed: 20040516
J Biol Chem. 2006 Nov 3;281(44):33789-801
pubmed: 16959785
Phys Med Rehabil Clin N Am. 2012 Feb;23(1):149-72, xii
pubmed: 22239881
Redox Biol. 2018 Jul;17:47-58
pubmed: 29673700
Am J Physiol Cell Physiol. 2008 Feb;294(2):C651-8
pubmed: 18171725
FASEB J. 2013 Jul;27(7):2600-10
pubmed: 23515443
J Cachexia Sarcopenia Muscle. 2017 Dec;8(6):1081-1083
pubmed: 29098794
Am J Physiol Heart Circ Physiol. 2010 Sep;299(3):H723-30
pubmed: 20562337
Nat Protoc. 2008;3(6):965-76
pubmed: 18536644
Am J Physiol Cell Physiol. 2009 Feb;296(2):C363-71
pubmed: 19109522
J Appl Physiol (1985). 2001 Mar;90(3):832-8
pubmed: 11181590
Nature. 2002 Aug 15;418(6899):797-801
pubmed: 12181572
Aging Cell. 2011 Jun;10(3):493-505
pubmed: 21385310
J Physiol. 2017 Oct 15;595(20):6409-6415
pubmed: 28792061
Am J Physiol Cell Physiol. 2009 Sep;297(3):C571-80
pubmed: 19605736
Physiol Genomics. 2003 Dec 16;16(1):29-37
pubmed: 14679299
J Clin Invest. 1991 Oct;88(4):1197-206
pubmed: 1918374
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):844-859
pubmed: 30168279
Free Radic Biol Med. 2006 Jun 1;40(11):1993-2004
pubmed: 16716900
J Physiol. 2003 Oct 1;552(Pt 1):283-93
pubmed: 12897166
Free Radic Biol Med. 2013 Aug;61:161-9
pubmed: 23567190
Aging Cell. 2010 Dec;9(6):1032-46
pubmed: 20849523
Free Radic Biol Med. 2010 May 1;48(9):1252-62
pubmed: 20156551
Aging Cell. 2012 Oct;11(5):770-82
pubmed: 22672615
J Cachexia Sarcopenia Muscle. 2018 Jun;9(3):435-440
pubmed: 29774990
Hum Mol Genet. 2015 Feb 1;24(3):625-36
pubmed: 25217571
Cell. 1988 Feb 26;52(4):503-13
pubmed: 3342447
J Physiol. 2006 Jul 1;574(Pt 1):319-27
pubmed: 16675492
J Cachexia Sarcopenia Muscle. 2019 Apr;10(2):411-428
pubmed: 30706998
Biochem Biophys Res Commun. 2002 Aug 23;296(3):729-36
pubmed: 12176043
Am J Physiol Regul Integr Comp Physiol. 2008 Aug;295(2):R659-68
pubmed: 18495829
Physiol Rev. 2000 Apr;80(2):853-924
pubmed: 10747208
Skelet Muscle. 2017 Nov 7;7(1):24
pubmed: 29115986
J Cachexia Sarcopenia Muscle. 2018 Oct;9(5):1003-1017
pubmed: 30073804
PLoS One. 2014 Jun 27;9(6):e100834
pubmed: 24971750
FASEB J. 2014 Apr;28(4):1666-81
pubmed: 24378874
Am J Physiol Regul Integr Comp Physiol. 2007 Sep;293(3):R1159-68
pubmed: 17584954
Ann Thorac Surg. 2009 Aug;88(2):543-50
pubmed: 19632410
Free Radic Biol Med. 2000 Feb 15;28(4):505-13
pubmed: 10719231
Am J Physiol Heart Circ Physiol. 2009 Apr;296(4):H1175-83
pubmed: 19252085
Am J Physiol Cell Physiol. 2009 Dec;297(6):C1520-32
pubmed: 19776389
J Neurochem. 2017 Dec;143(5):595-608
pubmed: 28902411
Biochemistry. 2011 Dec 20;50(50):10792-803
pubmed: 22091587
Placenta. 2008 Dec;29(12):985-94
pubmed: 18851882
Nat Genet. 1995 Dec;11(4):376-81
pubmed: 7493016
Skelet Muscle. 2014 May 23;4:10
pubmed: 24910770
J Physiol. 2001 Sep 1;535(Pt 2):591-600
pubmed: 11533147
FASEB J. 2013 Sep;27(9):3536-48
pubmed: 23729587

Auteurs

Bumsoo Ahn (B)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Rojina Ranjit (R)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Pavithra Premkumar (P)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Gavin Pharaoh (G)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.
Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Katarzyna M Piekarz (KM)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.
Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Satoshi Matsuzaki (S)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Dennis R Claflin (DR)

Department of Surgery, Section of Plastic Surgery, University of Michigan, Ann Arbor, USA.

Kaitlyn Riddle (K)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Jennifer Judge (J)

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, USA.

Shylesh Bhaskaran (S)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Kavithalakshmi Satara Natarajan (K)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Erika Barboza (E)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Benjamin Wronowski (B)

Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Michael Kinter (M)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.

Kenneth M Humphries (KM)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.
Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Timothy M Griffin (TM)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.
Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Oklahoma Center for Neuroscience, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Oklahoma City VA Medical Center, Oklahoma City, USA.
Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Willard M Freeman (WM)

Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Arlan Richardson (A)

Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Oklahoma City VA Medical Center, Oklahoma City, USA.
Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Susan V Brooks (SV)

Department of Molecular and Integrative Physiology, University of Michigan, Ann Arbor, USA.

Holly Van Remmen (H)

Aging and Metabolism Research Program, Oklahoma Medical Research Foundation, Oklahoma City, USA.
Department of Physiology, University of Oklahoma Health Sciences Center, Oklahoma City, USA.
Oklahoma City VA Medical Center, Oklahoma City, USA.
Reynolds Oklahoma Center on Aging, University of Oklahoma Health Sciences Center, Oklahoma City, USA.

Classifications MeSH